Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 51,500
-2,200 (-4.10%)
Jan 30, 2026, 3:30 PM KST
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 2.62 trillion as of January 30, 2026. Its market cap has increased by 28.61% in one year.
Market Cap
2.62T
Enterprise Value
2.60T
Revenue
154.05B
Ranking
n/a
PE Ratio
1,131.95
Stock Price
51,500.00
Market Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.62T, an increase of 9,843.84%. That is a compound annual growth rate of 16.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.62T | 17.71% |
| Dec 30, 2025 | 2.22T | 13.35% |
| Dec 30, 2024 | 1.96T | -12.72% |
| Dec 28, 2023 | 2.25T | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1.08T | -43.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 8.08T |
| Hanmi Pharm. | 6.58T |
| Celltrion Pharm | 3.20T |
| GC Biopharma | 1.97T |
| Daewoong Pharmaceutical | 1.96T |
| Ildong Pharmaceutical | 1.26T |
| Chong Kun Dang Pharmaceutical | 1.15T |
| Daewoong | 954.80B |